BSX vs CODX · P/E 20, rev $16.75B vs rev $3.9M
Boston Scientific Corp (BSX) versus Co-Diagnostics, Inc. Common Stock (CODX) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. CODX currently screens at market cap $31.4M.
Not investment advice. Open the BSX and CODX stock pages for the full models.
Not investment advice.